Earnings call transcript: Versigent tops Q3 2026 estimates as shares rise

Versigent exceeded Wall Street expectations for Q3 2026, reporting adjusted earnings per share of $1.91 on revenue of $2.45 billion. Sales increased 7% year-over-year despite a 2% dip in global automotive production. Adjusted EBITDA grew 11% to $275 million and the margin expanded to 11.2%. Shares surged 3.64% to $42.17 following the earnings release and an upgraded full-year cash flow outlook.

The company lifted its guidance for 2026 net sales to $9.5 billion to $9.6 billion, citing updated copper assumptions and higher pass-throughs. Versigent outperformed the broader automotive market for the sixth consecutive quarter, with strong growth in Asia Pacific and solid performance in the Americas.